Nucleating agents, methods for their production, and associated polymer compositions

US11414531B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11414531-B2
Application numberUS-201816609962-A
CountryUS
Kind codeB2
Filing dateMay 2, 2018
Priority dateMay 3, 2017
Publication dateAug 16, 2022
Grant dateAug 16, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method of manufacture of zinc monoglycerolate containing an incorporated modifier, and the product, the zinc monoglycerolate being in the form of agglomerates of crystallites, wherein the crystallite size based on the average coherence domain length is not more than 30 nm in the <100> direction, and not more than 60 nm in the <011> direction, as determined by the Scherrer equation via powder X-ray diffraction; and the aspect ratio computed by <100>/<011> coherent domain lengths is less than 0.65, preferably less than 0.56, in particular less than 0.44. Polymers containing this nucleating agent and methods for their production are also described. The zinc monoglycerolate is useful as a nucleating agent, and is very effective at low loading levels in polymers such as polypropylene.

First claim

Opening claim text (preview).

The invention claimed is: 1. A zinc monoglycerolate in the firm of agglomerates of crystallites, wherein: a crystallite size of the zinc monoglycerolate, based on average coherence domain length, is less than 30 nm in the <100> direction, which is along the <100> zone axis, and less than 60 nm in the <011> direction, which is along the <100> zone axis, as determined by the Scherrer equation via powder X-ray diffraction; an aspect ratio of the zinc monoglycerolate, computed by <100>/<011> coherent domain lengths, is less than 0.65; and wherein the zinc monoglycerolate is obtained by a process comprising reacting glycerol with a zinc compound, which is different from hydrozincite and is not derived from hydrozincite. 2. The zinc monoglycerolate according to claim comprising a modifier. 3. The zinc monoglycerolate according to claim 2 , wherein the modifier is a glycerol carboxylate ester. 4. The zinc monoglycerolate according to claim 3 , wherein the glycerol carboxylate ester is a saturated fatty acid ester of glycerol. 5. The zinc monoglycerolate according to claim 4 , wherein the glycerol carboxylate ester is glycerol monostearate. 6. The zinc monoglycerolate according to claim 2 , wherein an amount of modifier is between 1.0 and 5.0 mol % with respect to the zinc monoglycerolate. 7. A zinc monoglycerolate in the form of agglomerates of crystallites, comprising between 1.0 and 5.0 mol % of a glycerol carboxylate ester. 8. A process for preparing the zinc monoglycerolate according to claim 1 , the process comprising reacting all the zinc compound with glycerol and a modifier in the presence of an acid catalyst, wherein at least one of the following conditions is satisfied: the zinc compound is selected from the group consisting of zinc oxide, zinc carbonate, zinc hydroxide, zinc carboxylate and combinations thereof, and the reaction is conducted in the presence of less than 10% by weight water, based on the total weight of the reaction composition. 9. The process according to claim 8 , wherein the modifier is a glycerol carboxylate ester. 10. The process according to claim 8 , wherein an amount of the glycerol is between 90 and 110 mol % with respect to the zinc compound. 11. The process according to claim 8 , wherein an amount of the modifier is between 1.0 and 5.0 mol % with respect to the zinc compound. 12. The process according to claim 8 , wherein an amount of the acid catalyst is between 0.2 and 5 mol % with respect to the zinc compound. 13. A zinc monoglycerolate obtained by the process of claim 8 . 14. A composition, comprising an organic polymer and the zinc monoglycerolate of claim 1 . 15. The composition according to claim 14 , wherein the organic polymer is selected from the group consisting of a polyolefin, a polyvinyl chloride, a polystyrene, a polyacrylamide, a polyester, a polyamide, copolymers thereof, and copolymers of one or more of acrylonitrile, butadiene and styrene with each other or with another co-monomers. 16. The composition according to claim 14 , wherein the zinc monoglycerolate is present in an amount of 0.001% to 20% relative to the weight of the organic polymer. 17. The composition according to claim 14 , wherein the organic polymer is a polyolefin and the zinc monoglycerolate at a given loading level in the polyolefin provides a higher crystallisation temperature of the polyolefin than achieved with the same loading level of a zinc monoglycerolate having a crystallite size of greater than 30 nm in the <100> direction or of greater than 60 nm in the <011> direction or having an aspect ratio computed by <100>/<011> coherent domain lengths that is greater than 0.65. 18. The composition according to claim 14 , wherein the organic material is an isotactic polypropylene and the zinc monoglycerolate al a given loading level in the isotactic polypropylene pro's/ides a time to achieve 50% polymer crystallisation (t 1/2 ) at 140° C. that is at least 40% less than that achieved with the same loading level of a zinc monoglycerolate having a crystallite size greater than at least one of 30 nm in the <100> direction or of greater than 60 nm in the <011> direction, or having an aspect ratio computed by <100>/<011> coherent domain lengths that is greater than 0.65. 19. A process, comprising contacting the zinc monoglycerolate of claim 1 with an organic polymer such that the crystallisation temperature or a least one mechanical property of the organic polymer increases. 20. A nucleating agent, comprising the zinc monoglycerolate of claim 1 , which functions as a nucleating agent in an organic polymer.

Assignees

Inventors

Classifications

  • Metal alcoholates (titanates, zirconates C07F7/00) · CPC title

  • with polyalcohols · CPC title

  • Nucleating agents promoting the crystallisation of the polymer matrix · CPC title

  • by converting hydroxy groups to O-metal groups {(C07C29/09 takes precedence)} · CPC title

  • Propene · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11414531B2 cover?
A method of manufacture of zinc monoglycerolate containing an incorporated modifier, and the product, the zinc monoglycerolate being in the form of agglomerates of crystallites, wherein the crystallite size based on the average coherence domain length is not more than 30 nm in the <100> direction, and not more than 60 nm in the <011> direction, as determined by the Scherrer equation via powder …
Who is the assignee on this patent?
Basf Se, Micronisers Pty Ltd
What technology area does this patent fall under?
Primary CPC classification C08K5/057. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 16 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).